Navigation Links
eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
Date:2/11/2008

PHILADELPHIA, Feb. 11 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (Nasdaq: ERES), a leading provider of centralized electrocardiographic (ECG) collection and interpretation services including expert consultation and a provider of eClinical technology and services (electronic data capture and electronic patient reported outcomes solutions), announced today that it will release its 2007 fourth quarter results for the period ended December 31, 2007 on Tuesday, February 26, 2008 after the market closes. After the release, the Company will host a conference call at 5:00 PM ET later that day.

For the conference call interested participants should dial 866-578-5771 when calling within the United States or 617-213-8055 when calling internationally. Please use pass code 91743845. There will be a playback available as well. To listen to the playback, please call 888-286-8010 when calling within the United States or 617-801-6888 when calling internationally. Please use pass code 46120621 for the replay.

This call is being webcast by Thomson Financial and can be accessed at eRT's web site at http://www.eRT.com. The webcast may also be accessed at Thomson's Institutional Investor website at http://phx.corporate-ir.net/playerlink.zhtml?c=119164&s=wm&e=1764127 . The webcast can be accessed until February 26, 2009 on either site.

Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The
'/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
2. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
3. AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
4. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
5. Genta Announces Common Stock Offering of Approximately $3.1 Million
6. Chakshu Research Announces Appointment of Dr. Randall Olson as Director
7. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
8. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
9. Exelixis Announces February 14 Webcast of Its Fourth Quarter and Full Year 2007 Financial Results Conference Call
10. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
11. Biodel Inc. to Announce First Quarter Fiscal Year 2008 Financial Results on February 14, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 According ... Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity ... Development, Preclinical, Clinical Trial), by End Users - Global ... is expected to reach USD 2,107.99 million by 2020 ... of 15.29%. Browse more than ...
(Date:7/30/2015)... -- With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness of ... than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More ... Headquartered in Dallas, TX , ISN has additional offices ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, 2015 , ... As part of its ... raw material and technical service business units, Whitehouse Laboratories is pleased ... facility will be adjacent to the Container Center of Excellence and will be strictly dedicated ...
(Date:7/29/2015)... According to a new market research report, ,Global ... published by Mordor Intelligence, the Global market is expected to ... with North America being the largest ... market size. The Global market for Stem Cells is expected ... of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... Techne Corporation (NASDAQ: TECH ) (Techne) ... Tocris Holdings Limited and subsidiaries (Tocris), a leading supplier ... are used in both in-vitro and in-vivo experiments, to ... on making biologically active neuro- and bio-chemicals which are ...
... DNDN ) today reported results for the first quarter ended ... was $28.1 million compared to $21,000 for the quarter ended March ... quarter ended March 31, 2011 was $111.8 million, or $0.77 per ... quarter ended March 31, 2010 (which included a non-cash charge of ...
... Fla. and WAGENINGEN, Netherlands, May 2, 2011 ... global biotechnology company focused on the discovery, development, ... for the biopharmaceutical, biofuels and industrial enzyme industries, ... Dyadic Nederland B.V. ("Dyadic Netherlands"), has entered into ...
Cached Biology Technology:Techne Corporation Announces Acquisition 2Techne Corporation Announces Acquisition 3Techne Corporation Announces Acquisition 4Techne Corporation Announces Acquisition 5Dendreon Reports First Quarter 2011 Financial Results 2Dendreon Reports First Quarter 2011 Financial Results 3Dendreon Reports First Quarter 2011 Financial Results 4Dendreon Reports First Quarter 2011 Financial Results 5Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio 2
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
(Date:7/31/2015)... China , 31 de julio de 2015 /PRNewswire/ ... Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 de ... . La conferencia celebra su décimo aniversario ... ha convertido en una de las reuniones anuales más ... y es una de las conferencias científicas más dinámicas, ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... Cell biologist Carolyn Machamer, Ph.D is The ... her creative work on coronaviruses. Specifically, Machamer studies how ... against it. While most coronaviruses result only ... respiratory syndrome (MERS) and SARS can lead to fatal ...
... BioClaim, Inc. announced as part of its ongoing effort ... of Florida , a subsidiary of WellPoint, ... select physician offices in the state.  "We greatly ... Scott Kimmel , executive vice president and general counsel of ...
... Wash. Two nearly identical softballs, both approved for league ... player,s head., Those are the findings from a study conducted ... Materials Engineering and project engineer Derek Nevins that they will ... this month in Hong Kong. Their work was published in ...
Cached Biology News:BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida 2BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida 3Researchers hit virtual heads to make safer games 2
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
... with an early protein. ... hours post-infection exhibiting an intranuclear ... intensity between 6-24 hours. ... coarsely granular staining. No ...
... Anti-AP-2 α, clone 8G8/5 GenBank ... Bacterially made human AP-2alpha/gamma fusion protein corresponding ... residues 278-450 of human AP-2γ Formulation: 0.1M ... azide before the addition of glycerol to ...
Parathyroid Hormone Receptor 2 [PTHR2]...
Biology Products: